GLP-1s are linked to an increase in heart rate and number of ventricular events in patients with heart failure with reduced ejection fraction and implanted cardiac devices.

Researchers are developing non-invasive saliva tests to detect heart failure early, potentially before symptoms appear.

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

Acoramidis significantly reduced all-cause mortality in both wild-type and variant amyloid cardiomyopathy through 42 months of the ATTRibute-CM study. The study demonstrated consistent efficacy in ...

As Hungary’s healthcare system continues its journey of integration and modernization, the role of high-quality, timely ...

Findings from a prospective phase 2 clinical trial show that isatuximab (Sarclisa), an anti-CD38 monoclonal antibody, is an effective and well-tolerated treatment for patients with relapsed and/or ...

The global lateral flow assays market size is expected to reach USD 17.44 billion by 2033, registering a CAGR of 6.98% from 2025 to 2033, according to a new report by Grand View Research, Inc. The ...